| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |